Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference36 articles.
1. Arandjelovic K, Eyre HA, Lenze E, Singh AB, Berk M, Bousman C (2017) The role of depression pharmacogenetic decision support tools in shared decision making. J Neural Transm.
https://doi.org/10.1007/s00702-017-1806-8
2. Bose-Brill S, Xing J, Barnette DJ, Hanks C (2017) Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders. Pharmgenom Pers Med 10:247–252
3. Bousman CA, Hopwood M (2016) Commercial pharmacogenetic-based decision-support tools in psychiatry. Lancet Psychiatry 3:585–590
4. Bousman CA, Forbes M, Jayaram M, Eyre H, Reynolds CF, Berk M, Hopwood M, Ng C (2017a) Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools. BMC Psychiatry 17:60
5. Bousman CA, Jaksa P, Pantelis C (2017b) Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting. Pharmacogenet Genom 27:387–393
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献